| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vivos Therapeutics, Inc. (VVOS) has 0 insiders with recent SEC Form 4 filings, including 13 buys and 0 sells. VVOS is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 20, 2023 | Huntsman Ronald Kirk | Chief Executive Officer | Buy | 14,000 | $0.53 | $7,420.00 | +19.3% | |
| Jun 16, 2023 | Huntsman Ronald Kirk | Chief Executive Officer | Buy | 15,021 | $0.54 | $8,060.50 | +8.2% | |
| Jun 14, 2023 | Huntsman Ronald Kirk | Chief Executive Officer | Buy | 10,000 | $0.49 | $4,900.00 | +21.1% | |
| Dec 23, 2022 | Huntsman Ronald Kirk | Chief Executive Officer | Buy | 20,000 | $0.50 | $10,000.00 | +72.7% | |
| Jun 1, 2022 | Huntsman Ronald Kirk | Chief Executive Officer | Buy | 12,000 | $1.96 | $23,560.00 | +30.8% | |
| Sep 21, 2021 | Huntsman Ronald Kirk | Chief Executive Officer | Buy | 5,000 | $4.31 | $21,550.00 | +47.6% | |
| Aug 17, 2021 | Huntsman Ronald Kirk | Chief Executive Officer | Buy | 5,000 | $3.00 | $15,000.00 | +90.9% | |
| May 25, 2021 | Amman Bradford K. | Chief Financial Officer | Buy | 1,000 | $5.29 | $5,290.00 | +100.0% | |
| May 25, 2021 | Huntsman Ronald Kirk | Chief Executive Officer | Buy | 4,000 | $5.38 | $21,520.00 | +266.7% | |
| Dec 24, 2020 | Amman Bradford K. | Chief Financial Officer | Buy | 1,000 | $7.38 | $7,380.00 | New |